India's Bajaj Healthcare jumps on FDA report for Vadodara plant

Bajaj Healthcare

14/09/2023 05:55

** Shares of Bajaj Healthcare  BAJH.NS  rise as much as 8.2%
to 446 rupees, highest since Jan. 4
    ** Stock set to rise for a second straight session if gains
hold 
    ** Co on Wednesday said it received U.S. FDA's establishment
inspection report for its manufacturing site in Vadodara
    ** EIR had zero 483 observations, co added
    ** More than 970,000 shares change hands by 10:21 a.m. IST,
3.1x 30-day avg
    ** Volume above 800,000 for fourth session this month
    ** Stock up 2.6% as of 10:21 a.m. IST, trimming YTD losses
to 4.9%

 (Reporting by Anuran Sadhu in Bengaluru)
 ((Anuran.Sadhu@thomsonreuters.com ;))